Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing.
Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing.
复制标题
DOI:
10.1038/s41467-023-35886-6
复制
发表时间:
2023-01-13
影响因子:
16.6
通讯作者:
Chiarle, Roberto
中科院分区:
文献类型:
--
作者:
Tao, Jianli;Bauer, Daniel E.;Chiarle, Roberto
CRISPR-Cas gene editing has revolutionized experimental molecular biology over the past decade and holds great promise for the treatment of human genetic diseases. Here we review the development of CRISPR-Cas9/Cas12/Cas13 nucleases, DNA base editors, prime editors, and RNA base editors, focusing on the assessment and improvement of their editing precision and safety, pushing the limit of editing specificity and efficiency. We summarize the capabilities and limitations of each CRISPR tool from DNA editing to RNA editing, and highlight the opportunities for future improvements and applications in basic research, as well as the therapeutic and clinical considerations for their use in patients. CRISPR-Cas tools have shown exceptional promise in genome engineering over the past decade. Here the authors review the development of CRISPR-Cas9/Cas12/Cas13 nucleases, DNA base editors, prime editors, and RNA base editors, as well as their editing precision, off-target effects, and clinical considerations.
登录
查看更多内容
影响因子:
5.9
作者:
Biernacka A;Zhu Y;Skrzypczak M;Forey R;Pardo B;Grzelak M;Nde J;Mitra A;Kudlicki A;Crosetto N;Pasero P;Rowicka M;Ginalski K
通讯作者:
Ginalski K
DOI:
10.1126/science.aaf5573
发表时间:
2016-08-05
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Abudayyeh OO;Gootenberg JS;Konermann S;Joung J;Slaymaker IM;Cox DB;Shmakov S;Makarova KS;Semenova E;Minakhin L;Severinov K;Regev A;Lander ES;Koonin EV;Zhang F
通讯作者:
Zhang F
影响因子:
82.9
作者:
Cesana, Daniela;Calabria, Andrea;Montini, Eugenio
通讯作者:
Montini, Eugenio
影响因子:
16
作者:
Canela A;Sridharan S;Sciascia N;Tubbs A;Meltzer P;Sleckman BP;Nussenzweig A
通讯作者:
Nussenzweig A
影响因子:
14.9
作者:
Adikusuma F;Lushington C;Arudkumar J;Godahewa GI;Chey YCJ;Gierus L;Piltz S;Geiger A;Jain Y;Reti D;Wilson LOW;Bauer DC;Thomas PQ
通讯作者:
Thomas PQ